Re: Exempt Distribution
in response to
by
posted on
Mar 16, 2020 08:06PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Where are you seeing anything priced at $3.72
On SEDAR I see the Jan PP, 100,000 units (sh+1/2w) priced at $2.61 CAN w ex at $3.91 for 3 yrsÂ
Mar PP, 20,000 units (sh+1/2w) priced at $2.72 CAN w ex at $4.08 for 3 yrs